Related Experiment Video
Updated: Jan 30, 2026

Assessing Urinary Tract Junction Obstruction Defects by Methylene Blue Dye Injection
Published on: October 12, 2017
Assessment of kidney injury biomarkers in cats with obstructive and non-obstructive lower urinary tract disease
Sercan Hüseyin Bayendur1, Abuzer Acar1
1Department of Internal Medicine, Faculty of Veterinary Medicine, Afyon Kocatepe University, Afyonkarahisar, Turkey.
Background:
Feline lower urinary tract disease (FLUTD) is a common and potentially life-threatening condition in cats, with obstructive and non-obstructive presentations. This study aimed to evaluate tubular injury in cats with FLUTD using serum and urinary biomarkers.
Methods:
Forty male cats were enrolled and assigned to three groups: obstructive (n = 16), non-obstructive (n = 15) and healthy controls (n = 9). Urea nitrogen, creatinine, albumin and ELISA-based biomarker analyses (retinol-binding protein [RBP], N-acetyl-β-D-glucosaminidase [NAG], neutrophil gelatinase-associated lipocalin, cystatin-C [Cys-C], kidney injury molecule-1 [KIM-1] and interleukin-18 [IL-18]) were performed on serum and urine samples. The data were analysed using Kruskal‒Wallis test and Dunn's post hoc test.
Results:
Obstructive cats exhibited significantly elevated urinary RBP, NAG, KIM-1, IL-18 and albumin concentrations and indexes of RBP, NAG, Cys-C and KIM-1. Non-obstructive cats also showed elevations in urinary RBP and KIM-1.
Limitations:
The small sample size and absence of histopathological or follow-up data limit interpretation, although post hoc analysis showed strong power for most biomarkers except Cys-C and NAG.
Conclusion:
Our findings suggest that both obstructive and non-obstructive FLUTD may involve mild tubular stress. Since only a single time point was evaluated, it remains unclear whether these changes are transient or persistent. Monitoring RBP and KIM-1 may help identify early tubular alterations and support clinical assessment, but further validation is needed.
Related Concept Videos
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Chronic Obstructive Pulmonary Disease-V: Nursing Management
Assessment

